I put these data (radiographic chondrocalcinosis only) in the context of more sensitive CT data in this #GCAN2022 talk

https://twitter.com/rheum_cat/status/1583838087771090945?s=20&t=_VcvkscbXNnzzTkzYgzX3A

#ACR22

@TonyMerriman2@twitter.com @natalie_mccor@twitter.com @Tuhina_Neogi@twitter.com I love #YearinReview and there were FOUR of these at #GCAN2022

https://twitter.com/rheum_cat/status/1583462672133410817?s=20&t=itZMZw_JQcXtOohBt93JnQ

#ACR22

Highlighting again some #ICYMI excellent #gout #CPPD content from #GCAN2022

#ACR22

Here's the #CHIP study that @TonyMerriman2@twitter.com liked from #GCAN2022

#ACR22

@ashira_md@twitter.com @IreneBlancoMD@twitter.com @GrantSchulert@twitter.com @Tuhina_Neogi@twitter.com @SattuiSEMD@twitter.com @NicolaDalbeth@twitter.com #ACR22 #Crystals #CommunityHub
@nicoladalbeth@twitter.com

What's new in CPPD? An extension of #GCAN2022 discussions
Sunday 2:05-3:05PM ET

@ashira_md@twitter.com @IreneBlancoMD@twitter.com @GrantSchulert@twitter.com @Tuhina_Neogi@twitter.com @SattuiSEMD@twitter.com #ACR22 #Crystals #CommunityHub
@nicoladalbeth@twitter.com

Gout outcomes and adherence with @tuhina_neogi@twitter.com & other speakers
An extension of #GCAN2022 discussions
Sunday 1:00-2:00PM ET